PubRank

N J Yoo

Author PubWeight™ 58.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995 6.85
2 Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. Cancer Res 1999 1.74
3 Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias. Br J Cancer 2008 1.66
4 Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Oncogene 1999 1.59
5 Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancer. Cancer Res 1998 1.55
6 Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res 1999 1.47
7 Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res 1998 1.46
8 The JAK2 V617F mutation in de novo acute myelogenous leukemias. Oncogene 2006 1.34
9 Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers. Cancer Res 2001 1.31
10 Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. Hum Pathol 2001 1.27
11 Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar. J Invest Dermatol 2000 1.21
12 Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 2000 1.21
13 BRAF mutations in non-Hodgkin's lymphoma. Br J Cancer 2003 1.13
14 Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers. Cancer Res 1999 1.12
15 A simple, precise and economical microdissection technique for analysis of genomic DNA from archival tissue sections. Virchows Arch 1998 1.12
16 Alterations of Fas (APO-1/CD95) gene in transitional cell carcinomas of urinary bladder. Cancer Res 1999 1.06
17 9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of fas ligand and requires retinoic acid receptor and retinoid X receptor activation. Mol Cell Biol 1995 1.05
18 RNA polymerase sigma factor that blocks morphological differentiation by Streptomyces coelicolor. J Bacteriol 2001 1.05
19 Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506. Int Immunol 1996 1.01
20 Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma. Oncogene 2001 1.01
21 Absence of mutations in the kinase domain of the Met gene and frequent expression of Met and HGF/SF protein in primary gastric carcinomas. APMIS 2000 1.00
22 Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma. Am J Pathol 1999 0.98
23 Mutational and expressional analyses of STAG2 gene in solid cancers. Neoplasma 2012 0.97
24 A distinct region of chromosome 19p13.3 associated with the sporadic form of adenoma malignum of the uterine cervix. Cancer Res 1998 0.96
25 Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. J Pathol 2001 0.93
26 Mapping of a new target region of allelic loss at 21q22 in primary gastric cancers. Cancer Lett 2000 0.92
27 Chk1 frameshift mutation in sporadic and hereditary non-polyposis colorectal cancers with microsatellite instability. Eur J Surg Oncol 2007 0.91
28 Expression of Fas ligand in activated T cells is regulated by c-Myc. J Biol Chem 2000 0.90
29 BRAF mutations in acute leukemias. Leukemia 2004 0.89
30 Mutational analysis of JAK1 gene in human hepatocellular carcinoma. Neoplasma 2009 0.88
31 Genetic analysis of the LKB1/STK11 gene in hepatocellular carcinomas. Eur J Cancer 2004 0.87
32 Immunohistochemical localization of FAP-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues. APMIS 1999 0.86
33 Low frequency mutation of the Ephrin receptor A3 gene in hepatocellular carcinoma. Neoplasma 2009 0.86
34 In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas. J Pathol 1999 0.86
35 Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus. Biochem Biophys Res Commun 1997 0.85
36 Transitional cell carcinoma expresses high levels of Fas ligand in vivo. BJU Int 1999 0.85
37 Detection of soluble Fas mRNA using in situ reverse transcription-polymerase chain reaction. Lab Invest 1998 0.85
38 Inactivating mutations of KILLER/DR5 gene in gastric cancers. Gastroenterology 2001 0.84
39 Mutational analysis of the hCDC4 gene in gastric carcinomas. Eur J Cancer 2006 0.84
40 Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas. Cancer Res 1999 0.84
41 Mutational and expressional analysis of MLL genes in gastric and colorectal cancers with microsatellite instability. Neoplasma 2013 0.84
42 A distinct tumor suppressor gene locus on chromosome 15q21.1 in sporadic form of colorectal cancer. Cancer Res 2000 0.83
43 Immunohistochemical analysis of Fas ligand expression in normal human tissues. APMIS 1999 0.82
44 p53 mutations in solar keratoses. Hum Pathol 1996 0.80
45 Kinase domain mutation of MLK4 gene is uncommon in gastric and hepatocellular carcinomas. Dig Liver Dis 2005 0.79
46 Association of cyclin D1 G870A polymorphism with susceptibility to gastric cancers in Korean male patients. Neoplasma 2007 0.79
47 Regulation of CD95 ligand expression: a key element in immune regulation? Behring Inst Mitt 1996 0.79
48 Fas ligand is expressed in normal skin and in some cutaneous malignancies. Br J Dermatol 1998 0.79
49 Mutational analysis of Wnt pathway gene LEF1 in common human carcinomas. Dig Liver Dis 2007 0.78
50 KLF6 IVS1 -27G/A polymorphism with susceptibility to gastric cancers in Korean. Neoplasma 2008 0.78
51 Frameshift mutation at mononucleotide repeat in Apaf-1 is rare in gastric carcinomas. Dig Liver Dis 2008 0.77
52 Immunohistochemical analysis of Fas ligand expression in sarcomas. Sarcomas express high level of FasL in vivo. APMIS 1998 0.77
53 Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma. Br J Dermatol 2011 0.77
54 Frameshift mutations of OGDH, PPAT and PCCA genes in gastric and colorectal cancers. Neoplasma 2016 0.75
55 Absence of FES exon 16 and 17 mutation in the colorectal carcinomas in Korean patients. Dig Liver Dis 2005 0.75
56 Frameshift mutation at a mononucleotide repeat in CASP1 is rare in gastric and colorectal carcinomas with microsatellite instability. Dig Liver Dis 2008 0.75